Defective B cell response to TLR9 ligand (CpG-ODN), Streptococcus pneumoniae and Haemophilus influenzae extracts in common variable immunodeficiency patients

Cellular Immunology

Volumn 262, Issue 2, 2010, Pages 105-111

  Escobar, Danilo ^a   Pons, Jaime ^a   Clemente, Antonio ^a   Iglesias, Julio ^a   Regueiro, Verónica ^b   Bengoechea, José A ^b   Matamoros, Nuria ^a   Ferrer, Joana M ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

B cells; Common variable immunodeficiency; Toll like receptors

Indexed keywords

CD19 ANTIGEN; CD27 ANTIGEN; CD86 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; HAEMOPHILUS INFLUENZAE EXTRACT; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROBIOTIC AGENT; STREPTOCOCCUS PNEUMONIAE EXTRACT; T LYMPHOCYTE ANTIGEN; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL INFECTION; HUMAN; HUMAN CELL; HUMORAL IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOGLOBULIN DEFICIENCY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RESPIRATORY TRACT INFECTION; SIGNAL TRANSDUCTION;

ADULT; AGED; ANIMALS; ANTIGENS, CD19; ANTIGENS, CD86; B-LYMPHOCYTES; CELL EXTRACTS; CELL PROLIFERATION; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; HAEMOPHILUS INFLUENZAE; HUMANS; LIGANDS; MALE; MIDDLE AGED; OLIGODEOXYRIBONUCLEOTIDES; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE; TOLL-LIKE RECEPTOR 9; YOUNG ADULT;

BACTERIA (MICROORGANISMS); HAEMOPHILUS INFLUENZAE; STREPTOCOCCUS PNEUMONIAE;

EID: 77950867080     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.01.002     Document Type: Article

References (37)

1. Wood P., Stanworth S., Burton Recognition J., et al. Clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin. Exp. Immunol. 2007, 149:410-423.
2. Cunningham-Rundles C., Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin. Immunol. 1999, 92:34-48.
3. Bacchelli C., Buckridge S., Thrasher A.J., Gaspar H.B. Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency. Clin. Exp. Immunol. 2007, 149:401-409.
4. Iglesias J., Matamoros N., Raga S., Ferrer J.M., Mila J. CD95 expression and function on lymphocyte subpopulations in common variable immunodeficiency (CVID); related to increased apoptosis. Clin. Exp. Immunol. 1999, 117:138-146.
5. North M.E., Webster A.D., Farrant J. Defects in proliferative responses of T cells from patients with common variable immunodeficiency on direct activation of protein kinase C. Clin. Exp. Immunol. 1991, 85:198-201.
6. Ferrer J.M., Iglesias J., Hernandez M., Matamoros N. Alterations in interleukin secretion (IL-2 and IL-4) by CD4 and CD4 CD45RO cells from common variable immunodeficiency (CVI) patients. Clin. Exp. Immunol. 1995, 102:286-289.
7. Martinez-Pomar N., Raga S., Ferrer J.M., et al. Elevated serum interleukin (IL)-12p40 levels in common variable immunodeficiency disease and decreased peripheral blood dendritic cells: analysis of IL-12p40 and interferon-gamma gene. Clin. Exp. Immunol. 2006, 144:233-238.
8. Wehr C., Kivioja T., Schmitt C., et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008, 111:77-85.
9. Carsetti R., Rosado M.M., Donnanno S., et al. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J. Allergy Clin. Immunol. 2005, 115:412-417.
10. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2001, 2:675-680.
11. Janeway C.A., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 2002, 20:197-216.
12. Bernasconi N.L., Onai N., Lanzavecchia A. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 2003, 101:4500-4504.
13. Ruprecht C.R., Lanzavecchia A. Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur. J. Immunol. 2006, 36:810-816.
14. Bourke E., Bosisio D., Golay J., Polentarutti N., Mantovani A. The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood 2003, 102:956-963.
15. Cunningham-Rundles C., Radigan L., Knight A.K., Zhang L., Bauer L., Nakazawa A. TLR9 activation is defective in common variable immune deficiency. J. Immunol. 2006, 176:1978-1987.
16. Koga T., Lim J.H., Jono H., et al. Tumor suppressor cylindromatosis acts as a negative regulator for Streptococcus pneumoniae-induced NFAT signaling. J. Biol. Chem. 2008, 283:12546-12554.
17. Imasato A., Desbois-Mouthon C., Han J., et al. Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of toll-like receptor 2. J. Biol. Chem. 2002, 277:47444-47450.
18. Quah B.J., Warren H.S., Parish C.R. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat. Protoc. 2007, 2:2049-2056.
19. Cunningham-Rundles C. Immune deficiency: office evaluation and treatment. Allergy Asthma Proc. 2003, 24:409-415.
20. Piqueras B., Lavenu-Bombled C., Galicier L., et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J. Clin. Immunol. 2003, 23:385-400.
21. Bernasconi N.L., Traggiai E., Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002, 298:2199-2202.
22. Leadbetter E.A., Rifkin I.R., Hohlbaum A.M., Beaudette B.C., Shlomchik M.J., Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002, 416:603-607.
23. Viglianti G.A., Lau C.M., Hanley T.M., Miko B.A., Shlomchik M.J., Marshak-Rothstein A. Activation of autoreactive B cells by CpG dsDNA. Immunity 2003, 19:837-847.
24. Yu J.E., Knight A.K., Radigan L., et al. Toll-like receptor 7 and 9 defects in common variable immunodeficiency. J. Allergy Clin. Immunol. 2009, 124:349-356.
25. Chaturvedi A., Dorward D., Pierce S.K. The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens. Immunity 2008, 28:799-809.
26. Wang B., Lim D.J., Han J., Kim Y.S., Basbaum C.B., Li J.D. Novel cytoplasmic proteins of nontypeable Haemophilus influenzae up-regulate human MUC5AC mucin transcription via a positive p38 mitogen-activated protein kinase pathway and a negative phosphoinositide 3-kinase-Akt pathway. J. Biol. Chem. 2002, 277:949-957.
27. Echchannaoui H., Frei K., Schnell C., Leib S.L., Zimmerli W., Landmann R. Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J. Infect. Dis. 2002, 186:798-806.
28. Koedel U., Angele B., Rupprecht T., et al. Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J. Immunol. 2003, 170:438-444.
29. Lee K.S., Scanga C.A., Bachelder E.M., Chen Q., Snapper C.M. TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to Streptococcus pneumoniae. Cell. Immunol. 2007, 245:103-110.
30. Malley R., Henneke P., Morse S.C., et al. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. USA 2003, 100:1966-1971.
31. Srivastava A., Henneke P., Visintin A., et al. The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease. Infect. Immun. 2005, 73:6479-6487.
32. Branger J., Knapp S., Weijer S., et al. Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect. Immun. 2004, 72:788-794.
33. Albiger B., Dahlberg S., Sandgren A., et al. Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection. Cell. Microbiol. 2007, 9:633-644.
34. Mogensen T.H., Paludan S.R., Kilian M., Ostergaard L. Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns. J. Leukocyte Biol. 2006, 80:267-277.
35. Sen G., Khan A.Q., Chen Q., Snapper C.M. In vivo humoral immune responses to isolated pneumococcal polysaccharides are dependent on the presence of associated TLR ligands. J. Immunol. 2005, 175:3084-3091.
36. +-T-cell priming to young adult levels. Infect. Immun. 2006, 74:2177-2186.
37. Pons J., Ferrer J.M., Martinez-Pomar N., Iglesias-Alzueta J., Matamoros N. Costimulatory molecules and cytokine production by T lymphocytes in common variable immunodeficiency disease. Scand. J. Immunol. 2006, 63:383-389.